Cardinal Health, Inc. (NYSE:CAH - Get Free Report) has been given an average recommendation of "Moderate Buy" by the fifteen brokerages that are currently covering the firm, MarketBeat.com reports. Four research analysts have rated the stock with a hold rating and eleven have issued a buy rating on the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $133.29.
A number of research analysts have recently weighed in on CAH shares. Citigroup increased their target price on shares of Cardinal Health from $120.00 to $129.00 and gave the company a "neutral" rating in a research report on Friday, January 10th. Mizuho started coverage on Cardinal Health in a research note on Wednesday, December 4th. They issued an "outperform" rating and a $139.00 price objective on the stock. Wells Fargo & Company upgraded shares of Cardinal Health from an "underweight" rating to an "equal weight" rating and increased their target price for the stock from $101.00 to $127.00 in a research report on Friday, December 13th. StockNews.com lowered shares of Cardinal Health from a "strong-buy" rating to a "buy" rating in a research report on Sunday, November 3rd. Finally, TD Cowen upgraded shares of Cardinal Health from a "hold" rating to a "buy" rating and lifted their price objective for the company from $130.00 to $144.00 in a research note on Wednesday, January 8th.
Get Our Latest Stock Report on CAH
Institutional Investors Weigh In On Cardinal Health
Several hedge funds have recently added to or reduced their stakes in CAH. Eastern Bank purchased a new position in shares of Cardinal Health in the third quarter worth about $25,000. Frazier Financial Advisors LLC grew its position in Cardinal Health by 69.8% during the 3rd quarter. Frazier Financial Advisors LLC now owns 253 shares of the company's stock worth $28,000 after acquiring an additional 104 shares during the last quarter. Hara Capital LLC bought a new stake in Cardinal Health in the third quarter valued at approximately $31,000. AM Squared Ltd purchased a new stake in shares of Cardinal Health during the third quarter valued at approximately $33,000. Finally, Carolina Wealth Advisors LLC bought a new position in shares of Cardinal Health in the third quarter worth approximately $47,000. Institutional investors own 87.17% of the company's stock.
Cardinal Health Stock Performance
NYSE:CAH opened at $127.81 on Wednesday. Cardinal Health has a 52 week low of $93.17 and a 52 week high of $127.89. The firm has a 50-day moving average price of $120.92 and a two-hundred day moving average price of $112.47. The firm has a market cap of $30.93 billion, a price-to-earnings ratio of 24.87, a price-to-earnings-growth ratio of 1.54 and a beta of 0.63.
Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings results on Friday, November 1st. The company reported $1.88 EPS for the quarter, topping analysts' consensus estimates of $1.62 by $0.26. The business had revenue of $52.28 billion for the quarter, compared to analyst estimates of $50.90 billion. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. Cardinal Health's quarterly revenue was down 4.3% compared to the same quarter last year. During the same period last year, the company posted $1.73 earnings per share. As a group, sell-side analysts forecast that Cardinal Health will post 7.82 earnings per share for the current year.
Cardinal Health Cuts Dividend
The business also recently declared a quarterly dividend, which was paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd were issued a $0.5056 dividend. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.58%. The ex-dividend date of this dividend was Thursday, January 2nd. Cardinal Health's payout ratio is 39.30%.
Cardinal Health Company Profile
(
Get Free ReportCardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Featured Stories
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.